Recently, new parameters related to hypertension, such as variability in blood pressure and ambulatory arterial stiffness index (AASI), were demonstrated to correlate with arteriosclerotic change. In this study, we investigated the correlation between circadian variability in blood pressure/AASI and renal function. We also investigated differences in the clinical impact of 24 h, daytime and nighttime blood pressure variability on renal and systemic atherosclerotic changes. We analyzed data from 120 patients who underwent renal Doppler ultrasonography (RDU) and ambulatory blood pressure monitoring (ABPM) at our hospital ward, and investigated the correlation between circadian variability in blood pressure/AASI and renal function, including resistive index (RI) evaluated with RDU, which is thought to be a good indicator of renal vascular resistance. Subjects with higher circadian variability in systolic blood pressure (SBP) had significantly higher RI. Daytime variability in SBP correlated more strongly with RI than nighttime variability. Meanwhile, only nighttime variability, but not daytime variability, in SBP was related to carotid atherosclerosis. Similarly, AASI was significantly correlated with RI. Circadian variability in SBP and AASI were both significantly correlated with renal function. Daytime SBP s.d. was especially more strongly correlated with renal vascular resistance, and nighttime SBP s.d. was significantly correlated with intima-media thickness (IMT) and plaque score. These results indicate that evaluating both daytime and nighttime blood pressure variability enables an assessment of pathological conditions in hypertensive patients to prevent cardiovascular diseases.
INTRODUCTION
Much evidence establishes that hypertension involves an increased risk of cardiovascular disease, such as chronic kidney disease (CKD). 1, 2 To manage hypertensive patients, ambulatory blood pressure monitoring (ABPM) is widely recognized as a valuable examination, as previous studies reported that 24 -h blood pressure (BP) showed reproducible values and was more accurately correlated with cardiovascular diseases 3, 4 and prognosis 5, 6 than office BP.
Recently, in addition to 24-h BP, diurnal BP changes evaluated by ABPM, such as morning surge and nocturnal BP fall, was reported to correlate with cardiovascular disease and mortality. [7] [8] [9] We have also previously reported that the morning BP surge is significantly correlated with renal vascular damage. 10 Moreover, several studies showed that greater circadian variability (s.d.) in BP evaluated by ABPM caused aggravated target organ damage 11, 12 or increased the ratio of cardiovascular events. 13, 14 However, as mentioned above, diurnal BP changes, such as nocturnal BP fall or rise, is also reported to correlate with cardiovascular events, and these diurnal BP changes affect the 24-h variability; 15 therefore, the clinical impact of 24-h variability in BP might be disturbed. In fact, in a large population cohort study, Hansen et al. 16 indicated that 24-h BP variability did not contribute much to risk stratification over and beyond 24-h BP. Therefore, recent studies have investigated the clinical significance of daytime and nighttime variability and weighted variability that was not affected by nocturnal BP fall or rise, respectively. For example, daytime systolic blood pressure (SBP) variability was reported to correlate with target organ damage in hypertensive subjects, 17 and nighttime BP variability was reported to be a strong predictor of cardiovascular events in patients with type 2 diabetes. 18 However, there is still limited information about the correlation between circadian BP variability and renal atherosclerotic changes and the difference in clinical significance of the variability upon systemic atherosclerotic change.
Recently, Li et al. 19, 20 suggested a new index assessed from ABPM, ambulatory arterial stiffness index (AASI), which was a good indicator of arterial stiffness. They reported that AASI correlated well with other evaluations of arterial stiffness, such as pulse wave velocity and augmented index, and that AASI could provide prognostic information on cardiovascular mortality. Other studies showed that increased AASI is associated with target organ damage, decreased glomerular filtration ratio, or past history of stroke. [21] [22] [23] However, no study has directly investigated the correlation between AASI and renal atherosclerotic change.
Resistive index (RI: (peak systolic velocity Àend diastolic velocity)/ peak systolic velocity at segmental arteries in kidney) assessed by renal Doppler ultrasonography (RDU) is a valuable index of renal vascular resistance related to arteriosclerosis [24] [25] [26] and provides good prognostic information regarding renal function. [27] [28] [29] We also found that RI is a more efficacious index for evaluating very early renal damage than estimated glomerular filtration rate (eGFR). 10 Therefore, we think that renal vascular damage caused by atherosclerotic risk factors, such as circadian BP variability or AASI, could be evaluated more precisely by using RI.
In this study, we assessed the hypothesis that the circadian variability in BP and AASI correlates significantly with renal atherosclerotic change. We investigated the correlation between circadian BP variability (expressed as s.d.) and various renal function parameters, such as eGFR, RI and level of proteinuria. Additionally, we investigated the difference in clinical impact upon the renal and systemic atherosclerotic changes in 24-h BP variability, and daytime and nighttime BP variability and AASI.
METHODS

Study subjects and study design
In our hospital ward, almost all patients admitted for several internal diseases, such as diabetes mellitus, hypertension, dyslipidemia, CKD and so on, undergo RDU to evaluate renal arteriosclerotic changes. We initially enrolled 281 consecutive patients, with and without CKD, undergoing RDU in our hospital ward between February 2009 and May 2011. Patients were excluded if they had renal artery stenosis (n ¼ 16), renal transplant (n ¼ 1), or were on dialysis (n ¼ 1). Of the 263 patients, data from 120 patients undergoing ABPM to evaluate diurnal BP changes were analyzed in this study.
Subjects underwent biochemical examinations of blood and urine. Clinical parameters considered in this study included height, weight, body mass index (BMI), eGFR, serum lipid profile, fasting blood glucose, hemoglobin A1c (HbA1c), additional biochemical parameters, serum protein level, SBP and diastolic BP (DBP) at the time of RDU, smoking history and drug profile. Patients with diabetes mellitus were diagnosed according to the diagnostic criteria of the American Diabetes Association; fasting plasma glucose at or above 126 mg dl À1 , HbA1c X6.5%, a 2-h value in an oral glucose tolerance test at or above 200 mg dl À1 , or a random plasma glucose concentration X200 mg dl À1 in the presence of symptoms, or taking drugs for diabetes, and patients with hyperlipidemia were diagnosed as that; total cholesterol X220 mg dl À1 . LDL cholesterol X140 mg dl À1 , triglyceride X150 mg dl À1 , or taking drugs for hyperlipidemia. The Clinical Investigations Ethics committee of Osaka University Hospital approved the study protocol and written informed consent was obtained from all participants. The study was performed in according to the ethical principles of the Declaration of Helsinki and Good Clinical Practice standards.
Ultrasonographic determination
RI was calculated as: RI ¼ ðpeak systolic velocity À end diastolic velocityÞ/peak systolic velocity:
Patients were placed in a supine position, and the size of the left and right kidneys and the flow velocity in the aorta and renal arteries were evaluated to detect morphological abnormalities or renal artery stenosis. RI was determined in three different segmental arteries in both kidneys, and expressed as the mean of these values. This method was reported to be identical and technically easy to perform such that the reproducibility of RI could be improved. [30] [31] [32] Previous studies indicated that reliable RI measurements depended on proper measurement techniques that are performed by experienced operators. 33 In this study, Doppler examinations were performed by three experienced operators (T.K., K.K. and M.O.) using a XARIO SSA-660A ultrasound machine (Toshiba, Tokyo, Japan) with a 2.5-MHz sector transducer. Similarly, these specially trained technicians examined the echocardiograms and carotid ultrasonograms, and took the mean of three examinations as a representative measurement. Plaque score and the mean intima-media thickness (IMT) of the carotid artery were determined by carotid ultrasonography as previously reported. 34 Ambulatory blood pressure monitoring Ambulatory blood pressure was evaluated using portable monitors (FM-200, Fukuda Denshi, Tokyo, Japan) at 30-min intervals throughout the entire day or at 30-min intervals during the daytime (0700 hours to 2200 hours) and 60-min intervals at night (2200 hours to 0700 hours). In the present study, our subjects underwent ABPM in hospitalized condition. We defined circadian variability in BP as the s.d. in SBP, and we analyzed all-day SBP s.d., daytime (0700 hours to 2200 hours) SBP s.d. and nighttime (2200 hours to 0700 hours) SBP s.d. From SBP values obtained from ABPM, AASI was calculated as follows:
1 Àregression slope of DBP on SBP. 19 Renal function eGFR was calculated using the following equation: 35 eGFR ðml min The level of albuminuria was evaluated according to the American Diabetes Association classification. 36 The albumin/creatinine ratio in spot urine was used to classify proteinuria as follows: no proteinuria, o30 mg g À1 creatinine; microalbuminuria, 30-300 mg g À1 creatinine; clinical albuminuria, X300 mg g À1 creatinine.
Statistical analysis
Data were analyzed using JMP ver. 9.0.1 (SAS, Cary, NC, USA), and are presented as the mean±s.e.m. Differences between groups were analyzed employing the unpaired Student's t-test and Pearson's chi-square test. Multiple regression analysis was used to identify possible determinants of RI. A value of Po0.05 was regarded as significant. Table 1 reports the baseline clinical characteristics and usage of antihypertensive agents of the patients. The mean patient age was 68.8 ± 1.1 years.
RESULTS
First, we compared the characteristics between subjects with greater SBP s.d. and subjects with lower SBP s.d. (Table 2 ). In the all-day variability, subjects with greater SBP s.d. were significantly older, and had the morbidities of dyslipidemia and elevated HbA1c. There was also a significantly lower male-to-female ratio. In addition, subjects with greater SBP s.d. had significantly higher mean IMT and plaques as evaluated by carotid Doppler ultrasonography, and RI as evaluated by RDU. In daytime variability, subjects with greater SBP s.d. were significantly older, had higher BMI, the morbidities of diabetes mellitus, dyslipidemia and elevated HbA1c, and, moreover, significantly higher RI. In nighttime variability, subjects with greater SBP s.d. were significantly older, and had higher mean IMT, plaque score and RI. Similarly, Table 3 shows the comparison of baseline characteristics and parameters related to systemic atherosclerotic changes between higher and lower AASI. Subjects with higher AASI had significantly higher BMI and RI. There were no significant differences in the usage of respective class of antihypertensive agents Finally, using multiple regression analysis, we analyzed how SBP s.d. and AASI affect RI. Without adjustment, all-day SBP s.d., daytime SBP s.d., nighttime SBP s.d. and AASI were significantly correlated with RI (P ¼ 0.0005, Po0.0001, P ¼ 0.0017 and P ¼ 0.0005, respectively). In model 1, which was adjusted for traditional risk factors (age, sex, BMI, 24-h SBP (evaluated with ABPM)) and serum creatinine level, all-day SBP s.d., daytime SBP s.d. and AASI were significantly and independently correlated with RI (P ¼ 0.0041, P ¼ 0.0003 and P ¼ 0.0290, respectively). However, nighttime SBP s.d. was not significantly correlated with RI (P ¼ 0.0717). In model 2, which was adjusted for model 1 and with or without diabetes mellitus, dyslipidemia and proteinuria, all-day SBP s.d., daytime SBP s.d. and AASI were also significantly and independently correlated with RI (P ¼ 0.0120, P ¼ 0.0052 and P ¼ 0.0106, respectively). Meanwhile, nighttime SBP s.d. was not significantly correlated with RI (P ¼ 0.0879) ( Table 4) .
To further investigation, we conducted similar analyses using coefficient variant (CV) and obtained similar results. Subjects with higher SBP CV (all-day, daytime, nighttime) showed significantly higher age (P ¼ 0.0138, Po0.0001 and P ¼ 0.0017, respectively). Subjects with higher daytime SBP CV showed significantly lower eGFR (56.4 ± 2.5 vs. 66.4 ± 3.1, P ¼ 0.0062), on the other hand, there were no significant correlation between all-day SBP CV/nighttime SBP CV and eGFR (P ¼ 0.0958 and P ¼ 0.3260, respectively). Subjects with higher nighttime SBP CV showed significantly higher mean IMT (0.97 ± 0.04 vs. 0.84 ± 0.03, P ¼ 0.0101) and plaque score (7.89 ± 1.11 vs. 4.19±0.74, P ¼ 0.0036), meanwhile there were no significant correlation between all-day SBP CV/daytime SBP CV and mean IMT (P ¼ 0.1049 and P ¼ 0.1082, respectively) or plaque score (P ¼ 0.0783 and P ¼ 0.1495, respectively). And subjects with higher SBP CV (all-day, daytime, nighttime) showed significantly higher RI (0.73 ± 0.01 vs. 0.67 ± 0.01, P ¼ 0.0001, 0.73 ± 0.01 vs. 0.67 ± 0.01, Po0.0001 and 0.71 ± 0.01 vs. 0.68 ± 0.01, P ¼ 0.0224, respectively). We also conducted multiple regression analysis. Without adjustment, all-day SBP CV, daytime SBP CV, nighttime SBP CV were significantly correlated with RI (P ¼ 0.0008, Po0.0001, P ¼ 0.0017 and P ¼ 0.0140, respectively). In model 1, which was adjusted for traditional risk factors (age, sex, BMI, 24-h SBP (evaluated with ABPM)) and serum creatinine level, all-day SBP CV, daytime SBP CV were significantly and independently correlated with RI (P ¼ 0.0042, P ¼ 0.0003, respectively). However, nighttime SBP CV was not significantly correlated with RI (P ¼ 0.1785). In model 2, which was adjusted for model 1 and with or without diabetes mellitus, dyslipidemia and proteinuria, allday SBP CV, daytime SBP CV were also significantly and independently correlated with RI (P ¼ 0.0094, P ¼ 0.0057, respectively). Meanwhile, nighttime SBP CV was not significantly correlated with RI (P ¼ 0.1353).
DISCUSSION
In the present study, we report the correlation between the SBP s.d. or AASI and various parameters related to systemic atherosclerotic change including RI, IMT and plaque score. Higher circadian variability in SBP was significantly correlated with older age and BMI. Our study has several novelties. First, although RI was significantly correlated with all-day SBP s.d., daytime SBP s.d., nighttime SBP s.d. and AASI, we found that daytime SBP s.d. correlated more strongly with RI than other variabilities in SBP. Similarly, daytime SBP s.d. was significantly correlated with the morbidities of diabetes mellitus and elevated HbA1c, but nighttime SBP s.d. showed no significant correlation with HbA1c. Meanwhile, we also showed that nighttime SBP s.d. was significantly correlated with IMT, and plaque score, but daytime SBP s.d. showed no significant correlation with these parameters. These results are consistent with a previous report showing that nighttime BP variability could predict cardiovascular events in patients with type 2 diabetes, 18 as IMT and plaque score are well known to be strongly associated with stroke. [37] [38] [39] Moreover, in Figure 3 , the univariate analysis showed that nighttime SBP s.d., but not daytime SBP s.d., was significantly correlated with age.
Although the reason why daytime variability in BP and nighttime BP variability showed different impacts on clinical parameters related to atherosclerotic change is unclear. In addition to evidence showing that circadian BP variability is an early sign of autonomic dysfunction, 40 Eguch et al. 18 suggested that increased nighttime variability in SBP might be modulated by impaired parasympathetic activity. In contrast, Narkiewicz et al. 41 suggested that increased daytime BP variability is accompanied by increased sympathetic activity. Based on these results, we thought that daytime BP variability would correlate more strongly with RI and eGFR than nighttime BP variability because the sympathetic overdrive was reported to parallel the severity of renal failure, 42 and daytime BP variability was accompanied by increased sympathetic activity. Similarly, we thought that nighttime variability, not daytime variability in BP could be related to age and carotid atherosclerosis because decreased parasympathetic activity was reported to be associated with aging and carotid atherosclerosis independent of established risk factors. 43 Also, nighttime BP variability was accompanied by decreased parasympathetic activity. Recently, weighted s.d. in BP, which could exclude the confounding contribution of BP reduction between day and night, was found to be a convenient and useful index to correlate with end-organ damage. 44 However, the results of the present study indicate the clinical usefulness of using both daytime and nighttime variability in BP, not just all-day variability or weighted variability, to evaluate the pathological conditions of hypertensive patients to prevent cardiovascular diseases.
The second novelty of our study is that we used RI assessed by renal Doppler ultrasonography in all subjects. RI is a valuable index for evaluating renal vascular resistance, and RI reportedly serves as a useful marker to detect and evaluate atherosclerotic diseases due to cardiovascular risk factors, such as hypertension, diabetes mellitus, dyslipidemia and metabolic syndrome. [24] [25] [26] RI also provides good prognostic information for renal function. [27] [28] [29] Moreover, RI was significantly and independently correlated with histopathological atherosclerotic changes analyzed by renal biopsy. 45 In this study, circadian BP variability correlated more strongly with RI than eGFR. As eGFR is calculated easily from serum creatinine level, and age and sex are useful for renal function screening, it is generally difficult to assess the pathogenesis of CKD using only eGFR. RI could more accurately evaluate very early renal vascular damage than eGFR. 10 The present study, using RI to assess renal function and pathological change, could evaluate the clinical impact of BP variability and AASI on the kidney more precisely. We found that several variabilities in BP were significantly and independently correlated with RI, even after adjusting for traditional risk factors and serum creatinine level or albuminuria, showing that using BP variability in clinical practice, in addition to the traditional evaluation index of renal function, is useful. The present study has several limitations. First, as this study was an observational, cross-sectional study and the sample size was relatively small, larger longitudinal prospective studies are needed to evaluate the usefulness of circadian variability and AASI in predicting the progression of systemic atherosclerotic change and renal prognosis. Second, as this study was conducted at a university hospital and the study subjects were recruited there, many study subjects had already taken various orally administered drugs for hypertension, dyslipidemia and diabetes mellitus at the time of the investigation, and these agents might have affected several parameters, such as BP, lipid profile and so on. Third, as all of our subjects underwent ABPM in hospitalized condition, it is not clear that the diurnal variation, we evaluated in this study could be equal to diurnal variation in daily life, although ABPM in hospitalized condition enable us to evaluate the diurnal variation without being influenced much by external factors, such as change in temperature or stress about work. Finally, more frequent BP measurement at night (for example, 15-to 30-min interval) might reveal more accurate correlation between nighttime variability and various parameters even though some of previous studies adopted 60-min interval to evaluate nighttime BP in ABPM and showed meaningful results, 10,46 so further investigation is required about these points.
In conclusion, circadian SBP variability and AASI were both significantly correlated with renal function; daytime SBP s.d. was especially more strongly correlated with renal vascular resistance, and nighttime SBP s.d. was significantly correlated with IMT and plaque score. These results indicate that calculating both daytime and nighttime BP variability enable an evaluation of the pathological condition of hypertensive patients to prevent cardiovascular diseases.
